{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-24-001716","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2024-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.230873+00:00","generated_at":"2026-05-30T12:44:36.508210+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Lipella receives Nasdaq delisting notice for equity deficiency; hearing set for Dec 12","bullets":["Nasdaq notified Lipella of delisting for stockholders' equity of $1.7M, below $2.5M minimum.","Company appealed by Oct 23, 2024; hearing before Nasdaq Hearings Panel set for Dec 12, 2024.","Trading suspension stayed pending hearing; stock continues trading on Nasdaq during appeal.","Bid price non-compliance also outstanding; reverse split approved to address minimum bid requirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-24-001716","json":"https://secwatch.observer/filing/0001753926-24-001716.json","markdown":"https://secwatch.observer/filing/0001753926-24-001716.md","text":"https://secwatch.observer/filing/0001753926-24-001716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624001716/0001753926-24-001716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624001716/g084492_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:44:36.508210+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}